Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients.
about
Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis.Early rheumatoid arthritis: can we predict its outcome?Treating rheumatoid arthritis with new disease modifying drugs.Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?On the origin of rheumatoid arthritis: the impact of environment and genes--a population based twin studyTai chi and rheumatic diseases.Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study.Quality of life impacts on 16-year survival of an older ethnically diverse cohort.Dyslipidemia and rheumatoid arthritis.Mortality in rheumatoid arthritis patients with disease onset in the 1980s.Outcome of cervical spine surgery in patients with rheumatoid arthritisMortality in patients with rheumatoid arthritis treated actively from the time of diagnosis.Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study.Capability for daily activities in old people with rheumatoid arthritis: a population based studyMortality of rheumatoid arthritis in Japan: a longitudinal cohort studyAll-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists.Development and validation of a risk score for serious infection in patients with rheumatoid arthritis.Cardiovascular risks of cyclooxygenase inhibition.Apolipoprotein B-containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis.Pathogenesis of rheumatoid arthritis: its relevance to therapy in the '90s.Corticosteroids: do they damage the cardiovascular system?Hypertension in rheumatoid arthritis.Management of chronic nonmalignant pain with nonsteroidal antiinflammatory drugs. Joint opinion statement of the Ambulatory Care, Cardiology, and Pain and Palliative Care Practice and Research Networks of the American College of Clinical Pharmacy.Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study.Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies.The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment.Programmed initiation of hemodialysis for systemic amyloidosis patients associated with rheumatoid arthritis.Effect of disease-modifying antirheumatic drug therapy on immune response to trivalent influenza vaccine in rheumatoid arthritis.[Vaccination in patients from Brasília cohort with early rheumatoid arthritis].Mortality in Italian patients with rheumatoid arthritis: evidence for a low mortality rate from cancer and infections in patients followed up at a tertiary center.Association of physical inactivity with increased cardiovascular risk in patients with rheumatoid arthritis.Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients.Survival study of rheumatoid arthritis patients in Madrid (Spain). A 9-year prospective follow-up.
P2860
Q33224257-B13DE5B3-0015-43C3-AF14-5FBF0CE56B68Q34322390-2336FE36-F86D-444A-AD4D-69F179CAAE2CQ34567932-91F3020B-44E9-416F-BBEE-88A592E52336Q34601733-B7E0D0F4-540E-41FA-BD18-B6C5A45617DAQ34611984-3EA85EA0-FF69-45A8-9406-B155C36B7C5EQ34681950-6BFEC7E2-16D4-48D8-AE93-A3AB604D7062Q34923104-18F88F34-D2CC-4FD8-84DA-2BCD4BF2ED61Q35212934-477CE7D0-6B8D-4825-B805-3F68463504ABQ35547301-B06C757E-DCEA-4D57-98F8-3106C7CDE647Q35548197-C991EA64-A60A-4EB6-9897-FD840DC3D05DQ35550416-3B46C83D-E5FC-41C9-89D4-CD47AA6A1473Q35551023-9F03193D-17A9-4338-A58E-20A49B235178Q35554431-51C84C61-A562-46C6-87F8-98908861E032Q35554647-2C886429-0CE1-459B-AE84-562BFE7A7A3AQ35554834-C46D5498-2CB6-4E5C-9632-9C5E9E281EADQ35954490-5DBFB7F0-5CEB-46BA-AD09-C41FF8E2A536Q36179586-7CB1A630-4EF6-4DB5-A8F6-10308022AED7Q36520638-6E031863-AC0F-4232-A38B-E5FE597B776EQ36554649-02582DA4-39A2-493E-93F3-317B890C5FA5Q36647506-D5A2E91E-29DA-4A28-9A37-95ED1A45BEF9Q36679823-5FCF8C69-E4BF-4EC2-80F8-36A50D4D45B7Q37158219-552DF0FC-80D9-4D9E-AFCD-57F2CA593286Q37173212-142D5CB5-E9D4-41DB-94A2-256F7BEBEE90Q37350896-11756F14-328B-45AA-8C0B-E66FEFA39EB5Q37583248-0141C801-849A-4821-AE6F-CE57A49BB150Q38063474-AECB0891-9562-48EA-94EB-A050F1C4B562Q39888122-6967799D-D70B-4D06-8F7F-87BD24E92A2BQ40061605-5A6800DD-E73E-4672-986F-FED266A1CFBAQ40172149-0A6B88D7-C9E4-4D47-87C8-94681107FD34Q44461682-3EDC1E7B-072A-4E7F-9158-ED28DC747EA3Q46111865-42E58DC7-7FE5-4544-83C4-87AFFE89FFB5Q50701881-08158AF1-4AC0-4DD6-B1DD-0A1C5CF21F96Q54227851-4DE39F54-6A22-4CC2-B965-C9F7CA3F3054
P2860
Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients.
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Mortality and survival in rheu ...... pective study of 100 patients.
@ast
Mortality and survival in rheu ...... pective study of 100 patients.
@en
Mortality and survival in rheu ...... pective study of 100 patients.
@nl
type
label
Mortality and survival in rheu ...... pective study of 100 patients.
@ast
Mortality and survival in rheu ...... pective study of 100 patients.
@en
Mortality and survival in rheu ...... pective study of 100 patients.
@nl
prefLabel
Mortality and survival in rheu ...... pective study of 100 patients.
@ast
Mortality and survival in rheu ...... pective study of 100 patients.
@en
Mortality and survival in rheu ...... pective study of 100 patients.
@nl
P2093
P2860
P356
P1476
Mortality and survival in rheu ...... pective study of 100 patients.
@en
P2093
P2860
P304
P356
10.1136/ARD.49.6.363
P407
P577
1990-06-01T00:00:00Z